Skip to main content

Delphine Kervella

Institutions of which they are part

Postdoctoral researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Delphine Kervella

Institutions of which they are part

Postdoctoral researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Projects

Caracterización de la respuesta inmune celular específica frente al virus Epstein-Barr en receptores de trasplante renal pediátrico (CRICE-VEB)).

IP: -
Collaborators: Gema Ariceta Iraola, Laura Donadeu Casassas, Delphine Kervella
Funding agency: Sociedad Española de Trasplantes
Funding: 20000
Reference: SET/AYUDAS.PROYECTOS/2023/LOPEZ
Duration: 01/01/2024 - 31/12/2025

Desarrollo y validación de un algoritmo de predicción de la disfunción primaria del trasplante renal mediante el uso de inteligencia artificial y procesamiento de imágenes (Kidney Color)

IP: Enric Miret Alomar
Collaborators: Enric Trilla Herrera, David Lorente García, Aroa Gomez Brey, Maria Eugenia Semidey Raven, Delphine Kervella
Funding agency: Instituto de Salud Carlos III
Funding: 52500
Reference: PI24/00895
Duration: 01/01/2025 - 31/12/2027

Duacept, a novel bi-specific fusion protein to prevent transplant rejection

IP: Oriol Bestard Matamoros
Collaborators: Anna Martinez Lacalle, Delphine Kervella
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 165165
Reference: SLT036/24/000043
Duration: 21/12/2024 - 20/12/2026

RESETTING THE IMMUNOLOGICAL SYSTEM OF HYPERSENSITIZED TRANSPLANT CANDIDATES TO ALLOW ACCESS TO HLA COMPATIBLE KIDNEY TRANSPLANTATION (RESET TRIAL)

IP: Oriol Bestard Matamoros
Collaborators: Ana Pérez González, Franc Casanova Ferrer, Elena Isabel Crespo Gimeno, Laura Donadeu Casassas, Clàudia Carrera Muñoz, Maria Antonia Emilia Meneghini, Delphine Kervella
Funding agency: Instituto de Salud Carlos III
Funding: 465456.69
Reference: ICI24/00066
Duration: 01/01/2025 - 31/12/2029

Related news

The distinction from the Catalan Transplant Society will allow her to become a member of the Royal Academy of Medicine of Catalonia.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.

Related professionals

Cristina Aguilera Martin

Cristina Aguilera Martin

Main researcher
Clinical Pharmacology
Read more
Yolanda Cámara Navarro

Yolanda Cámara Navarro

Main researcher
Neuromuscular and Mitochondrial Pathology
Read more
Ramon Charco Torra

Ramon Charco Torra

Head of group
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Rafael Parra López

Rafael Parra López

Head of group
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.